EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography

Yuqi Du iD, Qing Chang, Shanshan Wang, Shuying Jing, Daguo Yang, Huan Cheng, Yifeng Li iD, Hang Zhou iD, Yuanyuan Chen, Tianle Qian iD, Shanshan Wu iD, Yong Tong

Biotechnology and Bioengineering · 2026-11-14

DOI: 10.1002/bit.70364 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-11-14. Written by Yuqi Du and 11 co-authors. Institution: WuXi Biologics Biosafety Testing (Suzhou) Co. Ltd., Suzhou, China. 12 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The continuous capture process, with its benefits of enhanced productivity, resin utilization, and reduced footprint, has significantly saved costs. Due to the complexity of three‐column periodic counter‐current chromatography (3 C‐PCC), a represented 3‐column scale‐down model (SDM) based on conventional ÄKTA equipment is still absent for viral clearance (VC) validation. This paper established a novel tailored SDM for mimicking the flow path of 3 C‐PCC based on conventional ÄKTA equipment and then validated its viral clearance capability. Variability in input material attributes and different process phases were considered when performing viral clearance assessments in this study. Comparable LRVs were achieved across different harvest stage (including early, middle and late harvests) and process state (including start‐up, steady and close‐down states), thereby providing valuable insights for designing viral clearance validation of 3C‐PCC. Moreover, the virus distribution patterns and carryover of the ÄKTA pcc SDM were investigated and generally consistent with batch mode, and there was no detectable virus residue in any column of ÄKTA pcc SDM post sanitization. Overall, this study established a novel 3C‐PCC SDM based on conventional ÄKTA equipment and provided valuable data to support future design of 3C‐PCC viral clearance validation.

Subjects

Author keywords

carryovercontinuous captureperiodic counter‐currentscale‐down modelviral clearance validationvirus distribution

Authors and institutions

  • WuXi Biologics Biosafety Testing (Suzhou) Co. Ltd., Suzhou, China.
  • WuXi Biologics (Shanghai) Co. Ltd., Shanghai, China.

ORCID profiles: Yuqi Du, Yifeng Li, Hang Zhou, Tianle Qian, Shanshan Wu

Cite

APA

Du, Y., Chang, Q., Wang, S., Jing, S., Yang, D., Cheng, H., Li, Y., Zhou, H., Chen, Y., Qian, T., Wu, S., & Tong, Y. (2026). A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70364

Vancouver

Du Y, Chang Q, Wang S, Jing S, Yang D, Cheng H, et al. A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70364

BibTeX
@article{Du2026,
  author = {Du, Yuqi and Chang, Qing and Wang, Shanshan and Jing, Shuying and Yang, Daguo and Cheng, Huan and Li, Yifeng and Zhou, Hang and Chen, Yuanyuan and Qian, Tianle and Wu, Shanshan and Tong, Yong},
  title = {A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70364}
}
Start for free →